ST. LOUIS--(BUSINESS WIRE)--TerraSource Global – a premier manufacturer of high-quality material sizing equipment based on the Gundlach, Jeffrey Rader and Pennsylvania Crusher brands, and subsidiary of Right Lane Industries – has announced the acquisi
VANCOUVER, British Columbia--(BUSINESS WIRE)--$KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and impl
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd (TSX and NYSE: NTR) announced today plans to release fourth quarter earnings results on Wednesday, February 15, 2023, after market close. Nutrien will host a conference call the following day, Thursday
HONOLULU--(BUSINESS WIRE)--#awardrecipients--Pacific Telecommunications Council (PTC) celebrated outstanding achievements in the information and communication technologies (ICT) industry, to improve the ability of people and firms in the Pacific region, a
VANCOUVER, Canada--(BUSINESS WIRE)--A new study published in the journal Antibiotics found that antimicrobial photodisinfection therapy (aPDT), using Ondine Biomedical Inc.’s (AIM: OBI) proprietary methylene blue-based photosensitizer in combination wit
Appili Therapeutics has named Dr. Carl Gelhaus as Director of Non-Clinical Research and Arthur Baran as Director of New Product Development for the ATI-1701 program. HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF
Company Seeking to Initiate Phase 1 Clinical Trial for its First-in-Class Multiple Sclerosis Drug Candidate TORONTO--(BUSINESS WIRE)--$HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biop
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--(TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. (“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported leadership changes, in
Global phase III with 605 patients from the US and eight European countries demonstrates therapeutic equivalence and safety between Stelara and DMB-3115 Aims to submit marketing authorization in the first half of 2023 for the US and the EU SEOUL, Sou
MONTRÉAL--(BUSINESS WIRE)--#Agriculture--Sollum Technologies (“Sollum“) has closed a $30 million financing round, including $25 million from Idealist Capital, a private equity manager that supports entrepreneurs at the heart of the energy transition
Seven Oaks Capital Corp.is pleased to announce that it has entered into a binding letter agreement dated January 29, 2023 (the "Definitive Agreement") with Rimon Hedge Funds Ltd.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.